Skip to main content
Clinical Trials/JPRN-jRCTs041180173
JPRN-jRCTs041180173
Active, not recruiting
未知

The multicenter study for purposes of detection of prognostic factor of advanced stage pediatric lymphoblastic lymphoma treated with standard chemotherapy - ALB-NHL-14

Mori Takeshi0 sites90 target enrollmentMarch 29, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Mori Takeshi
Enrollment
90
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 29, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Mori Takeshi

Eligibility Criteria

Inclusion Criteria

  • (1\) diagnosis of precursor T\-cell lymphoblastic lymphoma or precursor B\-cell lymphoblastic lymphoma (ratio of blast in bone marrow is less than 25%)
  • (2\) diagnosis of stage III/IV disease
  • (3\) age under 20 year old at diagnosis
  • (4\) registration at JPLSG CHM\-14 study
  • (5\) no history of previous anti\-cancer therapy except listed below ;
  • a) biopsy or surgical resection
  • b) emergency irradiation therapy within 7days
  • c) prednisolone therapy within 7 days
  • d) VCR or DNR therapy within 7 days in order to improve severe dyspnea
  • (6\) ECOG performance status (PS) score of 0\-2, or worsening to 4 due to lymphoma

Exclusion Criteria

  • (1\) Down syndrome.
  • (2\) Other previous illness of malignant tumor or previous therapy of organ transplantation including hematopoietc stem cells.
  • (3\) history of congenital or acquired immunodeficiency.
  • (4\) uncontrolled infection, including active tuberculosis infection and positive of HIV antibody.
  • (5\) pregnancy or high possibility of pregnancy and giving suck woman.
  • (6\) QTfc, corrected by Friderics formula as QTfc \= QT/RR\*1/3, is more than 0\.45 seconds.
  • (7\) CNS hemorrage more than grade 3 of CACAE v4\.0
  • (8\) MDS, Ph1 positive
  • (9\) any inappropriate status judged by

Outcomes

Primary Outcomes

Not specified

Similar Trials